Variant report
Variant | esv1813649 |
---|---|
Chromosome Location | chr1:224085956-224090857 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375474110 | chr1:224085963-224085964 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369954567 | chr1:224086022-224086023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564366991 | chr1:224086088-224086089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372707930 | chr1:224086186-224086187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528569986 | chr1:224086191-224086192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73116456 | chr1:224086215-224086216 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs562068951 | chr1:224086227-224086228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369738080 | chr1:224086258-224086259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186446810 | chr1:224086291-224086292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372886196 | chr1:224086305-224086306 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571712474 | chr1:224086316-224086317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377480180 | chr1:224086328-224086329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190915658 | chr1:224086389-224086390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74966021 | chr1:224086434-224086435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569988614 | chr1:224086439-224086440 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs150399863 | chr1:224086456-224086457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs138971946 | chr1:224086460-224086461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141173153 | chr1:224086528-224086529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370798253 | chr1:224086529-224086530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182906551 | chr1:224086532-224086533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1856205 | chr1:224086567-224086568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529064028 | chr1:224086597-224086598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs36031171 | chr1:224086641-224086642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs3908867 | chr1:224086646-224086647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530857141 | chr1:224086671-224086672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552388667 | chr1:224086677-224086678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs4098320 | chr1:224086691-224086692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs377371506 | chr1:224086724-224086725 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371239678 | chr1:224086735-224086736 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375498638 | chr1:224086771-224086772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570598279 | chr1:224086775-224086776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376762395 | chr1:224086784-224086785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187541664 | chr1:224086838-224086839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192964967 | chr1:224086853-224086854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs144481248 | chr1:224086855-224086856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs3872187 | chr1:224086868-224086869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535094488 | chr1:224086892-224086893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs3992795 | chr1:224086933-224086934 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557201379 | chr1:224086990-224086991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575511006 | chr1:224087001-224087002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569050011 | chr1:224087250-224087251 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs3992796 | chr1:224087256-224087257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs3992797 | chr1:224087280-224087281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546122813 | chr1:224087307-224087308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182971513 | chr1:224087309-224087310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573404072 | chr1:224087369-224087370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2126388 | chr1:224087383-224087384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs3992798 | chr1:224087396-224087397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540683034 | chr1:224087419-224087420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562058033 | chr1:224087447-224087448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Developmental delay | 21147756 | CNVD |
Autism | 14699429 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 20808228 | CNVD |
Fumarase deficiency | 21572526 | CNVD |
Autism | 17483303 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Leukoplakia | 24403051 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:224084800-224086400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
2 | chr1:224085000-224086000 | Weak transcription | Psoas Muscle | Psoas |
3 | chr1:224085400-224087400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr1:224085600-224086200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr1:224086000-224086400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
6 | chr1:224086000-224086400 | Enhancers | Brain Inferior Temporal Lobe | brain |
7 | chr1:224086000-224086400 | Enhancers | Psoas Muscle | Psoas |
8 | chr1:224086000-224086400 | Enhancers | NHDF-Ad | bronchial |
9 | chr1:224086200-224087600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr1:224087600-224087800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr1:224087600-224087800 | Enhancers | Fetal Muscle Leg | muscle |